GDS Wealth Management’s AbbVie ABBV Stock Holding History

GDS Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Buy	5,219 +574	+12%	+$123K	0.06%	87
2026 Q1	$1.01M	Buy	4,645 +414	+10%	+$91.8K	0.06%	88
2025 Q4	$967K	Hold	4,231	–	–	0.06%	93
2025 Q3	$980K	Buy	4,231 +167	+4%	+$34K	0.06%	95
2025 Q2	$754K	Buy	4,064 +27	+0.7%	+$5.02K	0.06%	98
2025 Q1	$846K	Buy	4,037 +1,381	+52%	+$268K	0.07%	93
2024 Q4	$472K	Sell	2,656 -69	-3%	-$12.7K	0.04%	115
2024 Q3	$538K	Hold	2,725	–	–	0.05%	93
2024 Q2	$467K	Hold	2,725	–	–	0.05%	87
2024 Q1	$496K	Sell	2,725 -790	-22%	-$136K	0.06%	90
2023 Q4	$545K	Buy	3,515 +1,180	+51%	+$172K	0.07%	80
2023 Q3	$348K	Sell	2,335 -27	-1%	-$3.96K	0.05%	92
2023 Q2	$318K	Sell	2,362 -460	-16%	-$67.5K	0.05%	102
2023 Q1	$450K	Buy	+2,822	New	+$431K	0.08%	79

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GDS Wealth Management's ABBV Position: Q2 2026 in Review

GDS Wealth Management increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $123K and bringing the position to 5,219 shares worth $1.31M. The position accounts for 0.06% of the portfolio, ranked #87.

GDS Wealth Management first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

GDS Wealth Management held 5,219 shares of AbbVie worth $1.31M as of Q2 2026.
GDS Wealth Management bought 574 AbbVie shares in Q2 2026, an estimated $123K.
AbbVie made up 0.06% of GDS Wealth Management's portfolio in Q2 2026, its #87 holding.
GDS Wealth Management first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GDS Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.